Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DYRK1A | Q13627 | 1/20 | 0.36 |
| ▸ | RPS6KA5 | O75582 | 2/20 | 0.34 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.33 |
| ▸ | GRIN1 | Q05586 | 3/20 | 0.31 |
| ▸ | GRIN2B | Q13224 | 3/20 | 0.31 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17437460 | 0.93 | RPS6KA5 (0.34) | RPS6KA5GRIN1GRIN2B | |
| SCHEMBL17437337 | 0.91 | GRIN2B (0.33) | RPS6KA5PTPN11GRIN1GRIN2B | |
| SCHEMBL17437589 | 0.91 | RPS6KA5 (0.31) | RPS6KA5GRIN1GRIN2B | |
| SCHEMBL17437411 | 0.89 | METAP2 (0.35) | RPS6KA5 | |
| SCHEMBL17437368 | 0.88 | RPS6KA5 (0.39) | RPS6KA5 | |
| SCHEMBL17437576 | 0.87 | HTR2C (0.35) | RPS6KA5PTPN11 | |
| SCHEMBL17437453 | 0.87 | RPS6KA5 (0.35) | RPS6KA5 | |
| SCHEMBL16053847 | 0.86 | RPS6KA5 (0.36) | RPS6KA5 | |
| SCHEMBL17437443 | 0.86 | PTPN11 (0.34) | RPS6KA5PTPN11 | |
| SCHEMBL17437584 | 0.86 | CYP3A4 (0.38) | RPS6KA5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170050963-A1 | MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES | SYNGENTA PARTICIPATIONS AG (CH) | 2017-02-23 | — | — | US | disclosed |
| US-9512120-B2 | Microbicidally active imidazopyridine derivatives | SYNGENTA PARTICIPATIONS AG (CH) | 2016-12-06 | — | — | US | disclosed |
| US-20160016949-A1 | MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES | SYNGENTA PARTICIPATIONS AG (CH) | 2016-01-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170050963-A1 | MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES | IDO1, IDO2, FOXM1 | DYRK1A 1399/4885RPS6KA5 2731/4885PTPN11 1630/4885 |
| US-20160016949-A1 | MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES | IDO1, IDO2, FOXM1 | DYRK1A 1399/4885RPS6KA5 2731/4885PTPN11 1630/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.